Literature DB >> 7297687

The effect of Ca2+ and the trifluoperazine on the processing of human acetylated low density lipoprotein by non-parenchymal liver cells.

T J van Berkel, J F Nagelkerke, J K Kruijt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7297687     DOI: 10.1016/0014-5793(81)80427-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  6 in total

1.  Quantitative analysis of antiatherosclerotic effect of nifedipine in cholesterol-fed rabbits.

Authors:  Y Ohta; N Higuchi; S Emura; T Takashima; K Oogushi; H Kato; K Ohmori; T Sunaga
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Processing of acetylated human low-density lipoprotein by parenchymal and non-parenchymal liver cells. Involvement of calmodulin?

Authors:  T J Van Berkel; J F Nagelkerke; L Harkes; J K Kruijt
Journal:  Biochem J       Date:  1982-11-15       Impact factor: 3.857

3.  Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia.

Authors:  S Wölle; D P Via; L Chan; J A Cornicelli; C L Bisgaier
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  Calcium is required for the expression of anthrax lethal toxin activity in the macrophagelike cell line J774A.1.

Authors:  R Bhatnagar; Y Singh; S H Leppla; A M Friedlander
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit.

Authors:  J M Wilson; D E Johnston; D M Jefferson; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

6.  Characterization of binding sites for acetylated low density lipoprotein in the rat liver in vivo and in vitro.

Authors:  H A Dresel; E Friedrich; D P Via; G Schettler; H Sinn
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.